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Myocardial Thallium-201 Kinetics and Regional Flow Alterations With
3 Hours of Coronary Occlusion and Either Rapid Reperfusion
Through a Totally Patent Vessel or Slow Reperfusion Through a
Critical Stenosis
JEROME E. GRANATO, MD, DENNY D. WATSON, PHD, TERRY L. FLANAGAN, BS,
GEORGE A. BELLER, MD, FACC
Charlottesville. Virginia
Myocardial thallium-2ot kinetics and regional blood flow
alterations were examined in a canine model using 3
hours of coronary occlusion and different methods of
reperfusion, Group I comprised 10 dogs undergoing a
3 hour left anterior descending artery occlusion and no
reperfuslon, Group II comprised seven dogs undergoing
3 hours of left anterior descending artery occlusion and
rapid reperfusion through a totally patent vessel. Group
III comprised 10 dogs undergoing 3 hours of left anterior
descendingartery occlusionand slow reperfusion through
a residual stenosis. All dogs received 1.5 mCi ofthallium-
201 after 40 minutes of coronary occlusion. During oc-
clusion and 2 hours of reperfusion, serial hemodynamic,
blood flow and myocardial thallium-201 activity mea-
surements were made.
The relative thallium-201 gradient (normal zone mi-
nus ischemic zone activity when initial normal activity
is expressed as 100%) during left anterior descending
coronary occlusion was similar in all groups. Group I,
87 ± 3%; Group II, 78 ± 6%; Group III, 83 ± 6%
(p =NS). After 2 hours of either method of reperfusion,
the final relative gradient had decreased to a similar
Restoration of coronary blood flow after varying periods of
coronary artery occlusion has been shown to limit infarct
size and improve survival in animal models (1-3). Despite
the documentation of clot lysis with thrombolytic therapy
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level (Group II, 51 ± 9%; Group III, 42 ± 6%).
These values were not significantly different from the
final relative thallium-201 gradient seen in dogs under-
going a sustained 3 hour occlusion (Group I, 55 ± 5%).
After 2 hours of reperfusion, both methods of reflow
were associated with similar degrees of "no reflow."
Transmural flows in the central ischemic zone were
89 ± 10% of normalin Group II and 71 ± 6% of normal
in Group III after reperfusion, with both flows substan-
tially higher than the relative thallium-201 activities in
these dogs. Infarct size (percent of left ventricle) deter-
mined with triphenyltetrazolium chloride was similar in
all groups (Group I, 24 ± 4%; Group II, 29 ± 4%;
Group III, 25 ± 4%).
Thus, in this experimental canine model, 3 hours of
coronary occlusion followed by either rapid reperfusion
through a totally patent vessel or slowreperfusion through
a critical stenosis resulted in little delayed thallium-2ot
redistribution or myocardial salvage as assessed histo-
logically, despite significant recovery of regional flow.
(J Am Coil CardioI1987;9:109-118)
in the clinical setting, assessment of myocardial salvage
after such therapy has been difficult. Myocardial thallium-
20 I scintigraphy has been used to assess improvement in
perfusion and resultant viability after reperfusion therapy
(4-11). When reperfusion is performed, however, thallium-
20 I uptake and washout kinetics may be altered, particularly
if thallium-201 is administered immediately after reperfu-
sion when hyperemia is present (12-15). Reperfusion of
ischemic myocardium has been shown to be associated with
cell swelling, subendocardial hemorrhage and interstitial
edema (16). These changes may alter thallium-Zlll uptake
and washout kinetics and may limit the extent of blood flow
restoration. Successful thrombolysis in patients with acute
myocardial infarction is often associated with a residual
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stenosis in the infarct vessel (17) . The presence of a high
grade stenosis in the infarct vessel after reperfusion may
alter ultimate myocardial blood flow restoration and myo-
cardial salvage when compared with rapid reperfusion through
a totally patent vessel.
We have previously shown (12) in a canine model using
I hour of coronary occlusion followed by 2 hours of re-
perfusion that no significant differences exist between slow
reperfusion through a critical stenosis and rapid reperfusion
through a totally patent vessel with regard to the extent of
blood flow restoration and thallium-201 uptake and washout
patterns . In the present series of experiments, we examined
whether, after 3 hours of coronary occlusion, rapid reper-
fusion through a totally patent vessel and slow reperfusion
through a critical stenosis differed with respect to myo-
cardial thallium-20l uptake and washout kinetics, the extent
of blood flow restoration and myocardial salvage. We have
extended the duration of occlusion in these experiments to
test the hypothesis that reperfusion superimposed on a more
severe ischemic insult might result in greater microvascular
damage that would be evidenced by less flow restoration
("no reflow ") and more pronounced alterations in myo-
cardial thallium kinetics. The extent of "no reflow " and
thallium abnormalities might be greater when the coronary
occluder is rapidly and totally released as compared with
reperfusion through a residual stenosis, which would atten-
uate the resultant hyperemia. On the other hand , the pres-
ence of a residual stenosis after reperfu sion might limit the
degree of flow recovery and ultimately the amount of myo-
cardial salvage . Such differences were not observed with
only I hour of occlusion (12) . Finally, because in only a
few clinical situations can thrombolytic therapy be admin-
istered after only 1 hour of coronary occlusion, these 3 hour
occlusion experiments will permit observations that may be
more clinically relevant.
Methods
Surgical preparation. Experiments were performed in
27 mongrel dogs (20 to 30 kg) that had fasted for 24 hours
before surgery. All dogs were anesthetized with pentobar-
bital sodium (30 mg/kg body weight intravenously) , intu-
bated and mechanically ventilated on a Harvard Apparatus
respirator, set at a rate of 13/min and a tidal volume of 500
cc. A limb lead of the electrocardiogram was continually
monitored. A femoral vein was isolated and a polyethylene
catheter (lntramedic 7450) inserted for the administration
of fluids and thallium-201 . Both femoral arteries were iso-
lated and catheters were introduced for simultaneous with-
drawal of microsphere reference samples and continuous
arterial pressure monitoring.
Figure 1 illustrates the surgical preparation. A thora-
cotomy was performed in the fifth left intercostal space and
the heart was suspended in a pericardial cradle. The prox-
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Figure 1. Diagrammatic illustration of the open-chest canine
model in whichthe left anteriordescending (LAD)coronaryartery
was instrumented with a hydraulic occluder, an electromagnetic
flow probe and a distal cannula for monitoring distal coronary
pressure. In dogs undergoing slow reperfusion through a residual
stenosis , a partially tight ligature was placed just distal to the
hydraulic occluder (below, right) .
imal portion of the left anterior descending artery was then
isolated and a hydraulic occluder (Rhodes Medical Instru-
ments , model VO-3) and an appropriately sized electro-
magnetic flow probe (Carolina Instruments) were placed
around the vessel. A 22 gauge angiographic catheter (Des-
seret) was inserted into a distal branch of the left anterior
descending coronary artery and connected to a Hewlett-
Packard 1280 pressure transducer to continuously monitor
the distal coronary pressure . A flared polyethylene tube was
placed in the left atrial appendage for pressure measurement
and for the injection of radiolabeled microspheres.
The technique for producing slow and rapid reperfusion
in this model has been previously described (12). In Group
III, 10 dogs undergoing slow reperfusion through a residual
stenosis, a partially tightened ligature was placed around
the vessel just distal to the hydraulic cuff occluder. This
ligature was progressively tightened to produce a critical
stenosis as defined by the absence of the reactive hyperemic
response after a 10 second occlusion. Group II, 7 dogs
undergoing rapid reperfusion through a patent vessel as sub-
sequently described, and Group I, 10 dogs undergoing a
sustained 3 hour occlusion without reflow, were not fitted
with the hydraulic occluder.
At the end of the experiment , the dog was killed and the
left ventricle and septum were separated from the remainder
of the heart , trimmed of epicardial fat and vessels and di-
vided into four layers from apex to base. Each layer was
then cut into eight transmural specimens. Specimens were
then divided into epicardial, midwall and endocardial spec-
imens . The sites from which myocardial biopsy specimens
were taken were recorded on a map ofthe epicardial surface
of the left ventricle, and the specific specimens used for
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Figure 2. Summary of experimental protocol in the three groups
ofdogs: Group I (sustained occlusion). Group II (fast reperfusion)
and Group III (slow reperfusion). Bx I, 2 and 3 = times of
obtaining myocardial biopsy samples; J-L sphere I, 2, 3 and 4 =
times of microsphere injections for determination of myocardial
blood fl ow (in minutes).
needle biopsy were identified for subsequent correlations
between flow and thallium-20l activity.
Experimental protocol (Fig. 2). Sustained coronary
occlusion: Group J. These 10 dogs underwent 3 hours of
sustained left anterior descending coronary artery occlusion
and no reperfusion.
Rapid reperfusion: Group // . These seven dogs under-
went rapid reperfusion through a totally patent vessel after
3 hours of left anterior descending coronary artery occlu-
sion. In these dogs, after 3 hours of occlusion, the occlusive
snare was quickly released, allowing rapid reflow through
a totally patent vessel.
Slow reperfusion: Group /J/ . These 10 dogs underwent
slow reperfusion through a critical stenosis. In these dogs,
after 3 hours of occlusion, the hydraulic occluder was grad-
ually released over 30 minutes, allowing restoration of flow
through the previously created critical stenosis. In all dogs.
1.5 mCi of thallium-20l was administered intravenously
after 40 minutes of coronary occlusion.
Protocol summary (Fig. 2) . All dogs were pretreated
with intravenous lidocaine (2 mg/kg) administered slowly
as a bolus, followed by a I mg/min drip infusion and an
intravenous heparin (50 U/kg) bolus. Additional lidocaine
was administered as needed during the experiments to con-
trol ventricular arrhythmias. Control hemodynamic data were
recorded and the first set of radioactive microspheres was
injected into the left atrium. Dogs in all three groups were
then subjected to a 3 hour total occlusion of the left anterior
descending coronary artery just after the first or second
diagonal branch. All dogs in Groups II and III underwent
2 hours of reperfusion. In each group, microsphere injection
and myocardial biopsy for thallium-201 activity were per-
formed at similar times (Fig. 2).
Thallium-201 activitydetermination. Transmuralmyo-
cardial biopsy was performed witha TravenolTru-Cut needle.
Nonischemic zone biopsy samples were obtained from the
high lateral wall in a region supplied by the left circumflex
artery. All ischemic zone samples were taken in the central
left anterior descending coronary artery region as delineated
by the area of central cyanosis after the total occlusion.
Final biopsy samples were obtained in duplicate. We have
previously shown (18) that, with this biopsy method, little
variation in thallium-20I activity in the center of the isch-
emic region is observed. All samples were analyzed in a
Packard auto-gamma scintillation spectrometer. Thallium-
20I activity in myocardial tissue samples was counted in
the 50 to 250 keY window.
Myocardial thallium-20 I time-activity curves were plot-
ted with values obtained from the serial biopsy samples.
Myocardial thallium-201 activity was expressed as percent
of the initial normal thallium-20l activity measured in the
initial biopsy sample obtained in the nonischemic region.
At the conclusion of the experiment , the heart was sec-
tioned into 96 segments for the assessment of regional myo-
cardial blood fl ow and thallium-20l activity. These samples
were then counted for 500 seconds in a Packard gamma
autoscintillation counter to measure final regional thallium-
201 activity. Measurements of regional thallium-20l were
averaged in four to fi ve adjacent segments on the posterior
wall to yield a normal thallium-20I activity for each heart.
Regional myocardial thallium-20I activity in all other sam-
ples was divided by this mean normal zone value to express
final regional myocardial thallium-20I activity as a percent
of normal zone activity. In order to better examine the
relations between the degree of ischemia and final thallium-
20I activity, sample values from each experiment were pooled
and stratified according to the degree of endocardial fl ow
reduction during left anterior descending coronary artery
occlusion. Stratification windowscomprised endocardial blood
flows between 0 and 20% of normal (severely ischemic),
21 and 40% (moderately ischemic), 41 and 60% (mildly
ischemic), 61 and 80% (minimally ischemic) and greater
than 80% of normal (nonischemic).
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Regional myocardial blood ftow determination. The
radioactive microsphere technique was used to assess re-
gional myocardial blood flow (19). For each determination,
approximately 2 X 106 microspheres (diameter, 8 to 10 p.)
were used. Myocardial samples were held for 2 weeks to
permit decay of the thallium-20I to appropriate levels to
allow counting formicrosphere activity. Samples were counted
for 500 seconds in a Packard gamma autoscintillation counter.
Separationof isotopes by energy windows (46SC = 740-1 ,300
95Nb = 650- 818 keV, 103Ru = 450-570 keV, 113Sn =
340- 440 keY) was performed according to the method of
Heyman et al. (19).
Regional myocardialbloodflow is expressed as a percent
of flow in the nonischemic or normal zone. Regional myo-
cardial blood flow in four to five adjacent segments on the
posterior wall was averaged for each microsphere injection.
The regional myocardial blood flow in each myocardial
segment examined at biopsy for thallium-201 activity was
then divided by the mean nonischemic flow value to yield
regional myocardial blood flow as a percent of the normal
zone value.
Myocardial infarct size determinations. Longitudinal
slicesof myocardium were incubated in triphenyltetrazolium
chloride dissolved in 3% Sorensen's buffer at 38°C for 20
minutes. Slices of myocardium were then photographed.
The areas of myocardial necrosis were outlinedand the area
of necrosis was computed using a video planimeter(Zeiss).
The percent necrosis of each slice was multiplied by the
weight of each slice to produce weight of necrotic tissue
per slice. These were totaled and divided by left ventricular
weight to produce the amount of myocardium infarcted (as
percent of left ventricle).
Statistical methods. All computations were performed
on a VAX 111750 computer. Data are expressed as
Table l. Experimental Hemodynamics in 27 Dogs
mean ± SEM. Statistical comparisons were performed uti-
lizing a one-way analysis of variance and appropriate t test
or Fisher's exact test.
Results
Hemodynamics. Table I shows the hemodynamic vari-
ables for each group of dogs. Heart rate was similar in all
groups and remained constant throughout the experiment at
approximately 135 beats/min. Mean arterial blood pressure
was initially similar in all groups. Blood pressure tended to
decrease during the experiment and a slight but significant
difference in blood pressure was noted between Group II
(rapid reperfusion) and III (slow reperfusion) after 2 hours
of reperfusion. In Group III, placement of a stenosis produced
an initial left anterior descending coronary artery pressure
gradient of 34 ± 4 mm Hg. At the end of the experiment
with the occlusion released but the stenosis still in place,
distal pressure in the artery was 60 ± 4 mm Hg and the
mean pressure gradient was 24 ± 5 mm Hg. The critical
stenosis was still effective in preventing the reactive hy-
peremic response. Peak reflow values measured by the elec-
tromagnetic flowmeter were different in Groups II and III
(69 ± 9 cc/min and 25 ± 3 cc/min, respectively [p <
0.05]), reflecting the different methods of reperfusion. The
critical stenosis caused a slight reduction in preocclusive
blood flow in Group III. There was, however, no difference
between preocclusiveand final leftanterior descending coro-
nary artery flows within each group (at 35 ± 4 - 35 ± 5
cc/min in Group II and 26 ± 3~ 21 ± 3 co/min in Group
Ill ).
Transmural myocardial thallium-2ot activity. Group
l . Figure 3 showsthe myocardial thallium-201 time-activity
curves from the transmural biopsy samples obtained in isch-
Distal
LAD
Pressure
Heart Rate (beats/min) Mean Arteria l Pressure (mm Hg) (mm Hg) LAD Flow (cc/m in)
Group Group Group Group Group Group Group Group Group Group
I II III I II III III I II III
Control 134 ± 7 138 ± 3 134 ± 5 101 ± 5 104 ± 3 101 ± 3 100 ± 3 30 ± 4 34 ± 4 30 ± 3
Stenosis 131 ± 7 138 ± 3 135 ± 5 100 ± 4 106 ± 4 104 ± 3 70 ± 3 30 ::!: 4 35 ± 4 26 ± 3*
Occ lusion time
I hour 133 ± 7 130 ::!: 6 134 ± 6 100 ± 5 99 ± 4 99 ± 5 30 ± 2 0 0 0
2 hours 138 ± 7 131 ± 7 131 ± 7 96 ± 6 106 ± 3 96 ± 3 30 ± 2 0 0 0
3 hours 144 ± 7 140 ± 6 133 ± 8 98 ± 6 109 ± 3 95 ::!: 2 33 ± 2 0 0 0
Reperfusion time
Peak 135 ::!: 9 131 ::!: 7 103 ::!: 3 95 ± 2 61 ::!: 3 69 ± 9 25 ± 3*
1 hour 129 ± 8 131 ± 7 98 ± 2 98 ± 4* 67 ± 4 36 ± 3 24 ± 2*
2 hours 135 ::!: 7 136 ::!: 9 98 ± 3 84 ± 4* 60 ::!: 4 35 ± 5 21 ± 3*
*p < 0 .05 compared with Group II. Groups I, II, III = dogs with permanent occlusion, rapid reperfusion and slow reperfusion, respectively.
LAD = left anterior descending coronary artery .
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Time (minutes post occlusion)
Figure 3. Myocardial thallium-201 time-activity curves from
ischemic and normal myocardium in nine dogs undergoing 3 hours
of sustained left anterior descending (LAD) coronary artery oc-
clusion (Group I). The initial nonischemic value is designated as
100%.
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Figure 4. Myocardial thallium-201 time-activity curves from
ischemic and normal myocardium in seven dogs undergoing 3
hours of coronary occlusion followed by a rapid reflow through a
totally patent vessel (Group II) . The initial nonischemic value is
designated as 100%.
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Figure 5. Myocardial thallium-201 time-activity curves from
ischemic and normal myocardium in 10 dogs undergoing 3 hours
of left anterior descending coronary artery occlusion followed by
slow reperfusion through a residual stenosis (Group Ill).
in 10 dogs undergoing 3 hours of occlusion followed by
slow reperfusion through the residual stenosis. In these dogs,
thallium-201 was administered after 40 minutes of coronary
occlusion, similar to the protocol followed for the group
with rapid and total reperfusion (Group II). After 175 min-
utes of coronary occlusion, thallium-201 activity in the cen-
tral ischemic region was 18 ± 6% of normal, comparable
with the degree of diminution in thallium-20l activity seen
in Group II. After2 hoursof reperfusionthroughthe residual
critical stenosis, ischemic zone thallium-201 activity in-
creased to 25 ± 7% of normal activity (p = NS compared
with Group II). The relative thallium-201 gradient between
the normal and ischemic zones decreased from 83 ± 6%
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emic and normal myocardiumof 9 of the 10dogs undergoing
3 hours of sustained left anterior descending coronary artery
occlusion; thallium-20I and flow data from 7 of these 9
dogs were previouslyreported (12). Ischemiczone thallium-
20I activity did not change during the 3 hour occlusion
period, being 14 ± 3% and II ± 2% of initial normal zone
thallium-201 activity (after 55 minutes and 180 minutes of
occlusion, respectively). During this period, the relative
thallium-201 gradientbetween the normalzone and the isch-
emic zones (with normal activity expressed as 100%) de-
creased from 87 ± 3% after 55 minutes of occlusion to
55 ± 5% after 3 hours of coronary occlusion (p < 0.05).
This change was primarily due to thallium-201 washout
from normal myocardium and not delayed thallium-201 ac-
cumulation in the ischemic zone (Fig. 3).
Group /I . Figure 4 shows the thallium-201 time-activity
curves from ischemicand normal myocardium for thisgroup
of seven dogs after 3 hoursof coronaryocclusionand sudden
total release of the left anterior descending coronary artery
occluder. After 175 minutes of occlusion, thallium-201 ac-
tivity in the central ischemic zone was 24 ± 6% of initial
normal activity. After 2 hours of reperfusion, ischemiczone
thallium-20I activity rose slightly but not significantly to
28 ± 5%. The relative thallium-201 gradient decreased
from 78 ± 6% (after 175 minutes of occlusion) to 51 ±
9% (after 2 hours of reflow) (p = NS compared with Group
III or Group I). In contrast to Group I, this diminution in
the relative thallium-201 gradient can be attributed to a
combinationof normal zone thallium-20I washoutand some
delayedaccumulationofthallium-201 in the ischemicregion
(Fig. 4).
Group 1JI. Figure 5 shows the myocardial thallium-201
time-activity curves from ischemic and normal myocardium
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Figure 6. Relation between initial endocardial, epicardial and
transmural blood flow during occlusion (% of initial normal [NL]
posterior wall flow) and final thallium-201 activity (% of final
normal posterior wall activity) at 2 hours of reflow. Samples from
the three groups of dogs are pooled and stratified according to
"windows" of initial flow reduction (line a == 0-20%; line b ==
21-40%; line c == 41-60%; line d == 61-80%; line e == 81-100%
flow reduction). Upward sloping reflects that thallium-20l redis-
tribution would have occurred. Downward sloping would reflect
"reverse" redistributionor enhanced thallium-201 washout (* ==
p < 0.05).
after 175 minutes of occlusion to 42 ± 6% after 2 hours
of reperfusion (p < 0.05). This change in the relative thal-
lium-20l gradient is not different from that seen in Group
lor Group 11 dogs. The diminution in the gradient was due
in part to some delayed thallium-20l accumulation in the
ischemic region but largely to washout of thallium-20 I from
the normal myocardium, as was observed in Group 11.
Regional myocardial thallium-2Ot activity (Fig. 6).
The sectioned myocardial segments from all dogs were
grouped according to the amount of flow reduction during
occlusion of the left anterior descending artery. Because
initial thallium-201 uptake is proportional to regional blood
flow over a physiologic range of flow values (18-20), the
regional blood flow during occlusion may be considered
comparable with initial regional thallium uptake. In Figure
6, the initial flow values are represented as percent of initial
normal flow values. Final thallium-20l activity was mea-
sured by gamma well counting in the segments sectioned
at postmortem to determine thallium activity at 2 hours after
reperfusion. Thallium activity was expressed as percent of
thallium found in the normally perfused posterior wall seg-
ments.
The most ischemic samples from Group I dogs (Fig. 6)
had an average initial blood flow of 7 ± I% and final
thallium concentration of 15 ± 1%, indicating slight re-
distribution. The higher final thallium activity relative to
initial flow is the result of thallium washout from the normal
control segments and retention of the small amount of thal-
lium delivered to the ischemic zone by way of collateral
vessels. After 2 hours of reperfusion, Group 11 and III dogs
also showed only a slight increase in thallium uptake relative
to initial flows within the most ischemic segments. A more
remarkable finding from these data is the lack of total thal-
lium-20l redistribution in segments with mildly reduced
blood flow where infarction would not be expected and
reflow should have been adequate to allow near total redis-
tribution. In fact, in some epicardial samples there was even
a tendency toward reverse redistribution in areas demon-
strating only an initial mild reduction in regional flow (Fig.
6, middle graphs for Groups 11 and III). This reverse dis-
tribution is characterized by the downward slope of the lines
connecting the initial flow values with the final thallium
values.
Regional myocardial flows. Figure 7 depicts regional
myocardial blood flow in the central ischemic zone as per-
cent flow in the normal zone. After 3 hours of left anterior
descending coronary artery occlusion, the reduction in en-
docardial blood flow and transmural blood flow was com-
parable in all three groups. In Group I, endocardial and
transmural flows remained diminished throughout 3 hour
occlusion. At 30 minutes of reperfusion in Group 11 dogs
Figure 7. Microsphere-determined regional endocardial and
transmural myocardial blood flow in the central ischemic zone (%
flow in normal zone) in the three groups of dogs at specific time
points (t in minutes) during the experiment.
Group 1- Sustained Occlusion (n=IO)
Group II-Fast Reperfusion (n=7)
Group ill-Slow Reperfusion (n=IO)
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Table 2. Extent of Myocardial Necrosis in 26 Dogs With
Permanent Occlusion or Occlusion With Reperfusion
*Differences between groups were not statistically significant; tOne
dog was excluded because of an inadequate biopsy sample for thallium-
201 determination.
periments is different from those previously used by other
groups to study reperfusion. The model allows reflow to
occur gradually over 30 minutes through a residual critical
stenosis. This model more likely mimics the clinical situ-
ation in which reperfusion occurs slowly as clot lysis pro-
gresses and is most often undertaken in the setting of a
residual stenosis. In our experiments, thallium-201 was ad-
ministered during coronary occlusion rather than after reflow
because we (12) and others (13-15) have shown that thal-
lium-20l administered soon after reperfusion when hyper-
emia is present may result in excessive thallium-20l uptake
in the infarcted region that does not reflect the true intra-
cellular thallium-201 concentration.
Thallium-2Ot activity in ischemic zone after reper-
fusion. In the present experiments, we observed a normal
thallium-20l washout pattern in the nonischemic zone in all
groups. In Group I (sustained occlusion) serial biopsy sam-
ples of the central ischemic zone revealed a persistently
reduced thallium-201 activity over 2 hours. When Groups
II (fast reperfusion) and III (slow reperfusion) were sepa-
rately analyzed there was a slight but not statistically sig-
nificant increase in ischemic zone thallium-201 activity after
reperfusion (Fig. 4 and 5) compared with that seen in Group
I dogs. Whereas this implies that after 3 hours of coronary
occlusion, reperfusion is associated with some delayed thal-
lium-201 accumulation in the central ischemic zone, it was
far less than that we reported for dogs undergoing I hour
of occlusion and reperfusion by both methods (12). This is
consistent with the histochemical analysis (Table 2), which
shows no statistically significant decrease in the extent of
myocardial necrosis with either method of reperfusion (Groups
II and III) compared with findings after sustained occlusion
(Group I). Reimer and Jennings (23) and Kloner and Alker
(24) showed that, in anesthetized dogs, rapid reperfusion
through a totally patent vessel after 3 hours of coronary
occlusion did not reduce the extent of myocardial necrosis
observed after 3 hours of sustained coronary occlusion. Our
data are consistent with this and also demonstrate that slow
reperfusion through a residual stenosis does not differ from
rapid reperfusion through a totally patent vessel with respect
to ultimate infarct size at the end of 2 hours of reflow.
(rapid and total reperfusion), central ischemic endocardial
flow was 102 ± 15% of normal and transmural flow in-
creased to 117 ± 19% of normal. After 2 hours of reper-
fusion, myocardial blood flows in these regions decreased
to less than the normal zone flow, reflecting the development
of no reflow. By 2 hours after reperfusion, central ischemic
zone endocardial blood flow had decreased to 68 ± 17%
and. transmural blood flow decreased to 89 ± 10% of nor-
mal.
In Group III dogs (slow reperfusion], flow to the reper-
fused bed was less than the normal zone flow after both 30
minutes and 2 hours of reperfusion. In this group, 30 min-
utes after reperfusion, central ischemic zone blood flow was
58 ± 8% and 89 ± II %, respectively, in the endocardium
and transmural sections. After 2 hours of reperfusion, en-
docardial and transmural flows were comparable in those
observed in Group II dogs at 69 ± 10% and 71 ± 6%,
respectively, but still significantly less than normal zone
flow. There was no difference between Groups II and III in
the extent of either endocardial or transmural flow resto-
ration in the central ischemic zone at 2 hours.
Histochemical staining (extent of myocardial necro-
sis). In Group I dogs (3 hour sustained coronary occlusion),
histochemical evidence of myocardial necrosis was seen in
the biopsy samples in all nine dogs subjected to this analysis;
infarct size averaged 27 ± 4% of the left ventricle by
weight. Necrosis involved most of the endocardial and mid-
epicardium and was frequently also transmural. In Group
II (rapid and total reperfusion), histochemical evidence of
myocardial necrosis in the biopsy samples was evident in
five of the seven samples stained. Infarct size averaged
29 ± 4% of the left ventricle by weight and was not sig-
nificantly different from infarct size measured in Group I
dogs. The area of necrosis was again observed throughout
most of the endocardium and midwall. In the epicardium
there were many islands of infarction. Similarly, in Group
III (slow reperfusion), histochemical evidence of myocardial
necrosis was seen in the region undergoing biopsy in all
seven dogs sampled. Infarct size averaged 25 ± 4% of the
left ventricle by weight. Again, the area of necrosis extended
throughout most of the endocardium with islands of necrosis
extending up to the epicardial surface. Gross evidence of
hemorrhage was seen in all samples in Groups II and III.
Thus, infarct size was virtually identical in all three groups
of dogs.
Discussion
Myocardial thallium-201 scintigraphy is frequently em-
ployed in the assessment of flow restoration and myocardial
viability following coronary reperfusion (4-11). There has
been considerable variability in the method by which thal-
lium-20 I is administered and the imaging techniques used
in these studies. One of the models employed in our ex-
Group
I (sustained occlusion)
II (rapid reperfusion)
III (slow reperfusion)
No.
9t
7
10
Infarct size
(percent of
left ventricle)*
27 ± 4%
29 ± 4%
25 ± 4%
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Threehoursversus 1 hourof coronary occlusion. Our
present findings are in distinct contrast to data from our
previous work (12), in which I hour of occlusion followed
by 2 hours of reperfusion resulted in markedly smaller areas
of necrosis than was observed in dogs undergoing 3 hours
of sustained coronary occlusion. One hour of coronary oc-
clusion followed by reperfusion in our previous study (12)
was associated with a significantly greater increase in de-
layed thallium-201 uptake in the reperfused zone than was
observed in the present study employing a 3 hour occlusion/2
hour reflow model. Again, in those earlier experiments,
there was no significant difference between rapid reperfu-
sion through a patent vessel and slow reperfusion through
a critical stenosis with respect to extent of infarction, degree
of delayed thallium-201 uptake or the extent of flow res-
toration.
Thallium activity values for ischemic segments strat-
ified for endocardial flow reduction. Thallium-201 activ-
ity values in the present experiments as well as those in our
previous work represent determinations made from biopsy
samples taken in the central ischemic zone. There may be
myocardial regions with lesser degrees of ischemia within
the area of risk of the occluded left anterior descending
coronary artery that might show more thallium-201 redis-
tribution after 2 hours of reperfusion. For this reason, we
assessed final thallium-20 I activity in all myocardial sam-
ples of the left ventricle, as measured by gamma well scin-
tillation counting of all myocardial samples prepared post-
mortem and compared these values with initial myocardial
flow in the same regions, which should be comparable with
the initial thallium-201 uptake values soon after thallium
administration. Over the physiologic range of blood flow
values, it is well established that initial thallium-20l uptake
is proportional to both flow (20,22) and the extraction frac-
tion for thallium-201 (25). The extraction fraction for thal-
lium-20l is also known to be constant over a wide range
of perfusion pressures (26). Thus, the comparisons in Figure
6 can actually be considered to depict the relations between
initial and final thallium-20 I activity for all myocardial seg-
ments stratified according to endocardial flow reduction dur-
ing occlusion. There was minimal thallium-20l redistri-
bution into the ischemic segments during 3 hours of occlusion
(Group I) and only slight partial redistribution after reflow
(Groups II and III), which is consistent with the view that
thallium is not extracted within the reperfused infarct. Un-
expectedly, there was minimal redistribution after reper-
fusion even in the myocardial segments with only a mild
or moderately reduced blood flow during the occlusion phase.
Failure to normalize thallium activity after reperfu-
sion. There are several possible explanations for this failure
to completely normalize thallium-201 activity after reper-
fusion in mildly and moderately ischemic segments as de-
fined by the magnitude of endocardial flow reduction during
occlusion. One is that after 3 hours of occlusion these sam-
ples contained a mixture of viable and nonviable cells. Hence,
as assessed by counting an entire sample, only partial nor-
malization of thallium-201 activity was observed. Segments
that had average flow reductions of 60 to 70% of normal
that failed to show complete normalization of thallium-201
activity may well have contained a mixture of viable and
nonviable myocardium, but there are other possible expla-
nations for failure to show complete normalization. One
possibility is that because of the long interval between thal-
lium-201 administration (during occlusion) andreperfusion,
plasma thallium-20l levels had fallen significantly, which
precluded greater thallium-201 uptake by any viable myo-
cytes during recirculation of thallium during the reperfusion
period. This is an unlikely explanation because previously
examined blood thallium-20l clearance after intravenous
injection of the radionuclide in an anesthetized canine model
and showed that there is little variation in blood thallium-
201 levels during 6 hours of observation (27). Another pos-
sible explanation for the failure of these myocardial seg-
ments with a mild decrease in endocardial flow to exhibit
delayed normalization of thallium-20 I uptake is that the final
biopsy samples were obtained too early and that, with a
longer reperfusion time, more thallium-201 accumulation
would have occurred (27). Finally, prolonged postischemic
mechanical dysfunction is well described (28-30) and it is
possible that the failure to completely normalize thallium-
20I activity at 2 hours of reflow is in part due to a prolonged
metabolic dysfunction of ischemic but viable myocytes. Per-
haps if thallium-201 was administered after permitting sev-
eral days of recovery, a greater degree of thallium- 20 I up-
take at the same levels of flow would be apparent. DeCoster
et al. (11) showed greater thallium uptake several weeks to
months after thrombolysis than was observed in 4 hour
redistribution images in the same patients.
Conclusions. These present data are consistent with our
previous work with I hour of occlusion and both models of
rapid or slow reperfusion (12). Our results support the hy-
pothesis that it is the duration of ischemic insult and not the
mode of reperfusion that determines the extent of flow res-
toration. Also, it appears that in the setting of 3 hours of
coronary occlusion, the extent of myocardial necrosis by
histochemical analysis is not altered by either method of
reperfusion. Serial determinations of transmural thallium-
20I activity reflected this by showing little delayed thallium-
201 uptake in the ischemic zone. Analysis of regional
thallium-20l activities in multiple myocardial regions re-
vealed that some myocardial segments with only mild flow
reductions also failed to demonstrate complete thallium-20l
normalization after reperfusion, raising the question of whether
these segments, though still possibly viable, had prolonged
postischemic metabolic dysfunction. Alternatively, some of
these segments could contain a mixture of normal and ne-
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erotic myocytes which would also prevent complete
thallium-20l redistribution despite an average flow that is
only mildly reduced.
Clinical implication. Demonstrating the efficacy of clin-
ical thrombolytic therapy by noninvasive means remains
difficult. Results of studies employing serial measurements
of left ventricular function as an indication of thrombolytic
efficacy have been conflicting (31,32). Serial imaging after
a single intravenous injection of thallium-201 has the ad-
vantage in that it could potentially provide pre- and postin-
tervention assessment of regional blood flow as well as an
indication of myocardial viability. The results of these cur-
rent experiments and data from our previously published
work (12) indicate that the longer the duration of occlusion,
the greater the degree of myocardial necrosis and the less
the degree of delayed thallium-201 redistribution, regardless
of whether the infarct-related vessel is rendered totally pat-
ent or has a residual stenosis at the time of reflow. These
experimental data lend support to prior clinical studies (9-11)
in which thallium-20l was administered during the occlu-
sion period and monitored after reperfusion. In these clinical
studies, successful reperfusion was associated with dimi-
nution ofthallium-201 defect size on serial images, whereas
in the instance of a persistently occluded infarct vessel, little
improvement in the thallium-20l defect observed during
occlusion was evident.
Several groups (33-37) have employed either percuta-
neous transluminal angioplasty alone or in combination with
thrombolysis as therapy for acute myocardial infarction. In
the clinical setting, however, it has not yet been determined
whether degree of restoration of nutrient flow and subse-
quent myocardial salvage after coronary reperfusion is sig-
nificantly enhanced by totally dilating the residual stenosis
in the infarct vessel after thrombolysis. Our data indicate
that in an acute anesthetized canine infarct model no sig-
nificant difference was observed with respect to ultimate
flow restoration by reperfusion through either a totally patent
vessel or a critical stenosis. Further, it is the duration of
coronary occlusion and not the mode of reperfusion that
determines the extentof flow restoration, delayed thallium-
201 uptake and myocardial salvage. Of course, extrapola-
tion of these data to the clinical setting must be made with
caution, recognizing that immense differences exist between
experimental canine myocardial infarction and clinical in-
farction.
We thank Elizabeth Howk for superb secretarial assistance and the New
England Nuclear Corporation for providing the radioactive microspheres.
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